Evidence map›Paper›PMID 42180966›Full record

ArticleTranslational cancer research2026

Comprehensive analysis and validation of the prognostic value of glycosylation- and mitophagy-related genes for head and neck squamous cell carcinoma.

Qiaoling Lu, Li Ying, Lang Ling, Wu Hui, Xinbin Wang

Abstract read
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiaoling LuDepartment of Anesthesiology, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, China.
Li YingDepartment of Oral and Maxillofacial Surgery, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, China.
Lang LingDepartment of Oral and Maxillofacial Surgery, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, China.
Wu HuiDepartment of Oncology, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, China.
Xinbin WangDepartment of Oral and Maxillofacial Surgery, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, China.ORCID https://orcid.org/0009-0002-6462-1124

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The treatment of head and neck squamous cell carcinoma (HNSCC) is particularly difficult because of its aggressive nature, complex anatomical location, and high recurrence and metastasis rates. This study investigated the relationship between glycosylation and mitophagy-related genes in HNSCC. Methods: We used bioinformatics tools to analyze data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Specifically, we analyzed differentially expressed genes (DEGs), mutations, copy number variations (CNVs), Gene Ontology (GO) enrichment, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment. Univariate and multivariate Cox regression analyses and Least Absolute Shrinkage and Selection Operator (LASSO) regression were performed to develop prognostic models, which were validated using GEO datasets. Results: We identified six key genes ( Conclusions: These findings highlight the diagnostic and prognostic potential of glycosylation- and mitophagy-related genes, laying the foundation for individualized HNSCC treatment.

Indexed as

glycosylationHead and neck squamous cell carcinoma (HNSCC)immune-cell infiltrationmitophagyprognostic model

Identifiers

PMID42180966
PMCPMC13190706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.